4/A: Perspective Therapeutics CEO Corrects Stock Ownership Reporting After Reverse Stock Split

Perspective Therapeutics CEO Johan Spoor files an amended Form 4 to correct previously reported stock ownership figures, adjusting for a reverse stock split.

Summary

• Perspective Therapeutics CEO Johan Spoor filed an amended Form 4 (Form 4/A) to correct errors in a previous filing.
• The original Form 4, filed on November 26, 2024, incorrectly reported the number of shares beneficially owned by Mr. Spoor.
• The errors stemmed from a failure to account for a 1-for-10 reverse stock split that occurred in June 2024.
• The corrected filing shows Mr. Spoor's direct ownership of common stock as 28,257 shares, down from the previously reported 152,072.
• Indirect ownership through his IRA is corrected to 5,400 shares, and indirect ownership through his spouse's IRA is corrected to 12,600 shares.
• Indirect ownership through a child is corrected to 1,000 shares.

Sentiment

Score: 4

Explanation: The document corrects a previous error, which is a negative, but it is a standard process. The correction itself is not a positive or negative, but the error is a negative.

Negatives

• The original Form 4 contained errors in reporting beneficial ownership.
• The errors were due to a failure to account for a reverse stock split.

Risks

• Inaccurate reporting of beneficial ownership can lead to regulatory scrutiny.
• Errors in filings can erode investor confidence.

Industry Context

This type of filing is standard for company insiders who have transactions in their company's stock. The correction highlights the importance of accurate reporting, especially after corporate actions like reverse stock splits.

Comparison to Industry Standards

• Form 4 filings are a standard requirement for company insiders in the US, and are used to report changes in beneficial ownership.
• The need for a Form 4/A to correct errors is not uncommon, and highlights the importance of accurate record keeping and reporting.
• Companies like Amgen, Gilead, and Regeneron also have similar filings when their executives trade shares.

Stakeholder Impact

• The correction of the filing ensures that shareholders have accurate information about insider ownership.
• The error in the original filing could have temporarily misled investors.

Key Dates

Keywords

beneficial ownership, Form 4, reverse stock split, SEC filing, stock ownership, Perspective Therapeutics, CATX, Johan Spoor